Search Results - "Winder, Matthew L"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    MCL-1 is a clinically targetable vulnerability in breast cancer by Winder, Matthew L, Campbell, Kirsteen J

    Published in Cell cycle (Georgetown, Tex.) (18-07-2022)
    “…Pro-survival members of the BCL-2 family, including MCL-1, are emerging as important proteins during the development and therapeutic response of solid tumors…”
    Get full text
    Journal Article
  2. 2

    The aryl hydrocarbon receptor contributes to tissue adaptation of intestinal eosinophils in mice by Diny, Nicola Laura, Schonfeldova, Barbora, Shapiro, Michael, Winder, Matthew L, Varsani-Brown, Sunita, Stockinger, Brigitta

    Published in The Journal of experimental medicine (04-04-2022)
    “…Eosinophils are potent sources of inflammatory and toxic mediators, yet they reside in large numbers in the healthy intestine without causing tissue damage. We…”
    Get full text
    Journal Article
  3. 3

    Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic function by Campbell, Kirsteen J., Mason, Susan M., Winder, Matthew L., Willemsen, Rosalie B. E., Cloix, Catherine, Lawson, Hannah, Rooney, Nicholas, Dhayade, Sandeep, Sims, Andrew H., Blyth, Karen, Tait, Stephen W. G.

    Published in Cell death and differentiation (01-09-2021)
    “…High levels of the anti-apoptotic BCL-2 family member MCL-1 are frequently found in breast cancer and, appropriately, BH3-mimetic drugs that specifically…”
    Get full text
    Journal Article
  4. 4